Asterias Biotherapeutics Inc Menlo Park, CA - 94025

Asterias Biotherapeutics Inc is categorized under Biological Research in Menlo Park, CA and active since 2012.

Asterias Biotherapeutics Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Thomas Okarma at the company’s single location by writing to 230 Constitution Drive, Menlo Park, California CA 94025 or by phoning (650) 433-2900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Asterias Biotherapeutics Inc
Contact Person: Thomas Okarma
Address: 230 Constitution Drive, Menlo Park, California 94025
Phone Number: (650) 433-2900
Website Address: biotimeinc.biz
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Asterias Biotherapeutics Inc was started in 2012 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Thomas Okarma for inquiries that concern Asterias Biotherapeutics Inc by calling the company number (650) 433-2900, as your correspondence is most welcome. Additionally, the physical location of the single location of Asterias Biotherapeutics Inc can be found at the coordinates 37.482527,-122.169456 as well as the street address 230 Constitution Drive in Menlo Park, California 94025.

For its online presence, you may visit Asterias Biotherapeutics Inc’s website at biotimeinc.biz and engage with its social media outlets through on Twitter and on Facebook.